Sitemap
January 13, 2009 Articles
Filter by Available Specialty
- ADA, AHA, ACC: Target glycemic goal should remain the same
- Alcon receives clearance to develop NovaBay compound for ocular infections
- ASCO: Patients with mCRC eligible for cetuximab should be tested for KRAS mutations
- Attorney advises surgeons: Use informed consent to avoid malpractice
- Dual-antibody therapy ineffective in mCRC with KRAS mutations
- MacuCLEAR, Mystic Pharmaceuticals enter agreement for trial of AMD drop
- Premium lens implants require premium clarity of the visual axis
- Thyroid hormone therapy and the skeleton